Aims and Scope
Drug Target Insights is an international, open access, peer-reviewed journal, covering current developments in all areas of the field of clinical therapeutics and focusing on molecular drug targets which include disease-specific proteins, receptors, enzymes, and genes. The journal seeks to elucidate the impact of new therapeutic agents on patient acceptability, preference, satisfaction and quality of life. The journal welcomes a wide range of article types, including original research, methodologies, case reports, reviews, perspectives, editorials and commentaries. Original research manuscripts may include in vitro and translational studies as well as all phases of animal or human/clinical studies. All articles are listed on PubMed and are freely available via PubMed Central.
Article Processing Charges (APCs)
There is no charge for submitting a paper to Drug Target Insights. Upon acceptance of your manuscript, you will be charged a one-time Article Processing Charge (APC). This fee covers the cost of publication and ensures that your article will be freely available. The APC is:
Authors in North America: USD $1848
Authors in other countries: GBP £1399
More information on article processing fees and availability of waivers and discounts is available on the article processing fees webpage, located here.
Standard Author Services
Submission to first editorial decision including rigorous, expert peer review in average four weeks
Rapid publication four weeks after acceptance
Open access visibility and flexibility with no restrictions on author archiving
CC-BY-NC licensing to prohibit unrestricted commercial re-use, CC-BY available on request
Article level usage metrics
Permanent availability by leading institutional libraries under CLOCKSS and LOCKSS systems
Proactive, professional journal staff
Manuscript Types and Preparation Guidelines
Information on manuscript types accepted for peer review and guidelines for manuscript preparation is available here. A template manuscript, sample manuscript, and pre-submission check list is available here.
All articles are subject to blind independent single-peer review by expert reviewers. Editorial decisions are made by Editors-in-Chief or Associate Editors. The editorial process from peer review to first editorial decision takes three to four weeks following acceptance of each paper for peer review.
In the open access business model many editorial decisions result in a fee payment to the publisher. Because of this we maintain a strict distinction between editorial decisions, made by Editors-in-Chief or Associate Editors, and business decisions. SAGE Publishing does not make nor attempt to influence editorial decisions. Editorial decision makers receive no incentives to make decisions leading to fee payments.
The journal is committed to high standards of integrity. Authors are required to confirm their compliance with ethical and legal requirements upon submission. Prior to publication all authors must provide signed confirmation of compliance. Where concerns arise the journal will apply the Committee on Publication Ethics guidelines on ethical matters.
Frequency of Publication
Articles are published online upon completion of production.
Article citations follow this format:
Authors: Title. Journal [year]:[volume] [first page]-[last page]
This is an open access journal. All content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access. All journals are indexed in the Directory of Open Access Journals (DOAJ) and are members of the Committee on Publication Ethics (COPE).
Contact details for SAGE Publishing are available here.
Additional Information for Authors